[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595546":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":55,"collaborators":12,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":12,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":12,"enrollmentInfo":67,"targetDuration":12,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":12,"overallStatus":40,"whyStopped":12,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Shahid Beheshti University of Medical Sciences","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard of care","NO_INTERVENTION","Advograf plus Cellcept plus Prednisolone",null,{"label":14,"type":6,"description":15,"interventionNames":16},"Intervention","Advograf plus Rapamiune plus Prednisolone",[17],"Drug: Rapamune Pill",[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","Rapamune Pill","Rapamiune Tablet 1mg daily plus Advograf plus prednisolone",[14],[25],"Sirolimus",[27],{"name":28,"affiliation":29,"role":30},"Dalili","SBMU","PRINCIPAL_INVESTIGATOR",[32],{"name":33,"role":34,"phone":35,"phoneExt":12,"email":36},"PI","CONTACT","00989122404331","dr.nooshindalili@gmail.com",[38],{"facility":39,"status":40,"city":41,"state":12,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Nooshin Dalili","RECRUITING","Tehran","1666663421","Iran","IR",{"type":46,"coordinates":47},"Point",[48,49],51.42151,35.69439,{"lat":49,"lon":48},[52],{"name":53,"role":34,"phone":35,"phoneExt":12,"email":54},"Nooshin Dalili, Dr","nooshindalili4@gmail.com",{"type":30,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"nooshin dalili","assistant professor","100595546","evaluaion-the-short-term-effects-of-advograf-plus-rapamiune-after-kidney-transplantation-100595546",false,"NCT07033858","Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation","Investigating the Effect of Low-dose Extended-release Tacrolimus and Sirolimus on the Short-term Outcomes of Allograft Kidney Transplantation","Inclusion Criteria:\n\n* All Kidney transplant recipients\n\nExclusion Criteria:\n\n* Kidney-Pancreas transplant BMI\\>30 cPRA\\>0%","ALL","18 Years",{"count":68,"type":69},50,"ESTIMATED","INTERVENTIONAL",[72],"NA","Cornerstone immunosuppressive therapy currently relies on immediate-release tacrolimus, a calcineurin inhibitor (CNI) that is potentially nephrotoxic and is more diabetogenic than cyclosporine A. A new formulation of tacrolimus has been launched: an extended-release formulation (Advagraf®\u002FAstagraf XL®, Astellas company).",[75],"Kidney Transplant; Complications","2025-06-14",{"date":78,"type":79},"2025-06-24","ACTUAL",{"date":81,"type":79},"2025-03-01",{"date":83,"type":69},"2026-07-01",{"name":5,"class":6},1]